Prediction of Drug-Drug Interaction between Phenobarbital and Theophylline in Children using Physiologically-Based Pharmacokinetic Modelling 2019 年 10 月 17 日 By webdev
Development of a PBPK model for the prediction of Amiodarone pharmacokinetics in fed and fasted state using ADAM model 2019 年 10 月 17 日 By webdev
The Certara Quantitative Systems Toxicology & Safety (QSTS) Pharma Consortium: Overview and Invitation to Join 2019 年 10 月 17 日 By webdev
Quantitative Systems Toxicology Approach Integrates Simcyp PBPK and Core Hepatocyte Metabolism: a Case Study with Valproic Acid 2019 年 10 月 16 日 By webdev
Prediction of mAb disposition in hepatic impairment – Evolocumab as a case study 2019 年 10 月 15 日 By webdev
Use of a physiologically based pharmacokinetic – pharmacodynamic (PBPK-PD) model to guide dose adjustments to S-warfarin in different populations 2019 年 10 月 15 日 By webdev
Biopharmaceutic In Vitro In Vivo Extrapolation (IVIV_E) Informed PBPK Model of Ritonavir Norvir® Tablet Absorption in Humans Under Fasted and Fed State Conditions 2019 年 10 月 15 日 By webdev
Accounting for CYP2C19 mechanism based inhibition and CYP1A2 induction in a PBPK model for omeprazole 2019 年 10 月 11 日 By webdev
Physiological verification of a geriatric population using the Simcyp R package 2019 年 10 月 11 日 By webdev